Post-operative Analgesic Effects of Dexamethasone Added to Bupivacaine in Transversusabdominis Plane (TAP) Block
Comparison of Post-operative Analgesic Effects of Two Doses of Dexamethasone Added to Bupivacaine in Ultrasound-guided Transversusabdominis Plane (TAP) Block for Inguinal Hernia Repair
1 other identifier
interventional
90
1 country
1
Brief Summary
To compare the postoperative analgesic effect of two doses of dexamethasone added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Mar 2019
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2019
CompletedFirst Posted
Study publicly available on registry
March 5, 2019
CompletedStudy Start
First participant enrolled
March 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedApril 28, 2020
April 1, 2020
9 months
March 3, 2019
April 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
time of the first analgesic request
time of the first analgesic request in the first postoperative 24 hours ,patients will receive analgesia if visual analog scale (VAS) score more than 3
in the first postoperative 24 hours
Secondary Outcomes (1)
change in visual analog scale (VAS)
2nd, 4th, 8th, 16th, and 24th postoperative hours.
Study Arms (3)
Dex4 group
ACTIVE COMPARATORAfter the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
Dex8 group
ACTIVE COMPARATORAfter the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
control group
ACTIVE COMPARATORAfter the surgery, the patients in this group will 1mg/kg of 0.5% bupivacaine in the TAP block.
Interventions
After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.
After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.
Eligibility Criteria
You may qualify if:
- Patients' age from 18 to 60 years old,
- physical status ASA I-II (by the American Society of Anesthesiologists),
- Elective unilateral open inguinal hernia repair,
- Under spinal anesthesia
You may not qualify if:
- age \< 18 or \> 60,
- American society of anesthesiologist (ASA)class III-IV,
- known allergy to amino amide local anesthetics,
- skin infection and diseases at site of injection.
- coagulation disorders,
- patients with body mass index (BMI) \> 35 kg/m2,
- scrotal hernias,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university hospitals
Asyut, Assiut Governorate, Egypt, 715715, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amany Hassan, Lectural
Assiut university, Egypt
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- A blinded physician prepared the study medications in color coded syringes.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 3, 2019
First Posted
March 5, 2019
Study Start
March 15, 2019
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
April 28, 2020
Record last verified: 2020-04